1. Home
  2. SRDX vs ETJ Comparison

SRDX vs ETJ Comparison

Compare SRDX & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • ETJ
  • Stock Information
  • Founded
  • SRDX 1979
  • ETJ 2007
  • Country
  • SRDX United States
  • ETJ United States
  • Employees
  • SRDX N/A
  • ETJ N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • ETJ Finance Companies
  • Sector
  • SRDX Health Care
  • ETJ Finance
  • Exchange
  • SRDX Nasdaq
  • ETJ Nasdaq
  • Market Cap
  • SRDX 562.6M
  • ETJ 623.2M
  • IPO Year
  • SRDX 1998
  • ETJ N/A
  • Fundamental
  • Price
  • SRDX $38.61
  • ETJ $9.19
  • Analyst Decision
  • SRDX Hold
  • ETJ
  • Analyst Count
  • SRDX 4
  • ETJ 0
  • Target Price
  • SRDX $43.00
  • ETJ N/A
  • AVG Volume (30 Days)
  • SRDX 219.6K
  • ETJ 175.6K
  • Earning Date
  • SRDX 11-06-2024
  • ETJ 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • ETJ 8.30%
  • EPS Growth
  • SRDX N/A
  • ETJ N/A
  • EPS
  • SRDX N/A
  • ETJ N/A
  • Revenue
  • SRDX $126,078,000.00
  • ETJ N/A
  • Revenue This Year
  • SRDX $13.75
  • ETJ N/A
  • Revenue Next Year
  • SRDX $13.67
  • ETJ N/A
  • P/E Ratio
  • SRDX N/A
  • ETJ N/A
  • Revenue Growth
  • SRDX N/A
  • ETJ N/A
  • 52 Week Low
  • SRDX $25.17
  • ETJ $7.20
  • 52 Week High
  • SRDX $42.44
  • ETJ $8.47
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 50.28
  • ETJ 46.72
  • Support Level
  • SRDX $37.86
  • ETJ $9.17
  • Resistance Level
  • SRDX $38.93
  • ETJ $9.33
  • Average True Range (ATR)
  • SRDX 0.40
  • ETJ 0.10
  • MACD
  • SRDX 0.08
  • ETJ -0.00
  • Stochastic Oscillator
  • SRDX 62.29
  • ETJ 42.86

About SRDX Surmodics Inc.

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials.

Share on Social Networks: